| pubmed-article:10638398 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10638398 | lifeskim:mentions | umls-concept:C0442118 | lld:lifeskim |
| pubmed-article:10638398 | lifeskim:mentions | umls-concept:C0012291 | lld:lifeskim |
| pubmed-article:10638398 | lifeskim:mentions | umls-concept:C0005508 | lld:lifeskim |
| pubmed-article:10638398 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:10638398 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10638398 | pubmed:dateCreated | 2000-2-11 | lld:pubmed |
| pubmed-article:10638398 | pubmed:abstractText | A comparison of the pharmacokinetic properties of two novel intranasal preparations of dihydroergotamine mesilate (DHEM) with a commercially available intranasal preparation. | lld:pubmed |
| pubmed-article:10638398 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10638398 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10638398 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10638398 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:10638398 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:10638398 | pubmed:author | pubmed-author:MerkusF WFW | lld:pubmed |
| pubmed-article:10638398 | pubmed:author | pubmed-author:HooymansP MPM | lld:pubmed |
| pubmed-article:10638398 | pubmed:author | pubmed-author:LohmanJ JJJ | lld:pubmed |
| pubmed-article:10638398 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:10638398 | pubmed:author | pubmed-author:Ter BergJ WJW | lld:pubmed |
| pubmed-article:10638398 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10638398 | pubmed:volume | 55 | lld:pubmed |
| pubmed-article:10638398 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10638398 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10638398 | pubmed:pagination | 677-80 | lld:pubmed |
| pubmed-article:10638398 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:meshHeading | pubmed-meshheading:10638398... | lld:pubmed |
| pubmed-article:10638398 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10638398 | pubmed:articleTitle | Bioavailability of intranasal formulations of dihydroergotamine. | lld:pubmed |
| pubmed-article:10638398 | pubmed:affiliation | Department of Pharmacy, Laurentius Hospital, Roermond, The Netherlands. H.vanderKuy@lzr.nl | lld:pubmed |
| pubmed-article:10638398 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10638398 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10638398 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10638398 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
